| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.00045 | 1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |